Sollis Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
Sollis Therapeutics General Information
Description
Developer of non-steroid and non-opioid analgesics intended to treat pain conditions affecting large numbers of people. The company's drug is an extended-release combination of analgesic and anti-inflammatory medication purpose-built for targeted local delivery for the treatment of sciatica and other neuropathic pain syndromes, enabling healthcare providers to offer proper therapy for pain.
Contact Information
Website
www.sollistx.comCorporate Office
- PO Box 450
- Hilliard, OH 43026
- United States
Corporate Office
- PO Box 450
- Hilliard, OH 43026
- United States
Sollis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Jan-2024 | Completed | Clinical Trials - Phase 3 | |||
| 5. Early Stage VC | 25-Mar-2021 | Completed | Clinical Trials - Phase 3 | |||
| 4. Early Stage VC | 25-Aug-2020 | Completed | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC (Series A) | 12-Apr-2018 | Completed | Clinical Trials - Phase 3 | |||
| 2. Grant | 08-Dec-2017 | $2M | Completed | Clinical Trials - Phase 3 | ||
| 1. Corporate | 01-Jan-2017 | Completed | Startup |
Sollis Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sollis Therapeutics Comparisons
Industry
Financing
Details
Sollis Therapeutics Competitors (17)
One of Sollis Therapeutics’s 17 competitors is Bridge Therapeutics, a Venture Capital-Backed company based in Birmingham, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bridge Therapeutics | Venture Capital-Backed | Birmingham, AL | ||||
| Phoenix PharmaLabs | Venture Capital-Backed | Salt Lake City, UT | ||||
| Semnur Pharmaceuticals | Formerly VC-backed | Palo Alto, CA | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Pacira BioSciences | Formerly VC-backed | Tampa, FL |
Sollis Therapeutics Signals
Sollis Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cardinal Health | Corporation | Minority | ||
| Medtronic | Corporation | Minority | ||
| The Ohio State University | University | Minority | ||
| Ohio Department of Development | Government | |||
| Neurotechnology Innovations Translator | Corporation | Minority |
Sollis Therapeutics FAQs
-
When was Sollis Therapeutics founded?
Sollis Therapeutics was founded in 2017.
-
Where is Sollis Therapeutics headquartered?
Sollis Therapeutics is headquartered in Hilliard, OH.
-
What is the size of Sollis Therapeutics?
Sollis Therapeutics has 4 total employees.
-
What industry is Sollis Therapeutics in?
Sollis Therapeutics’s primary industry is Drug Discovery.
-
Is Sollis Therapeutics a private or public company?
Sollis Therapeutics is a Private company.
-
What is Sollis Therapeutics’s current revenue?
The current revenue for Sollis Therapeutics is .
-
How much funding has Sollis Therapeutics raised over time?
Sollis Therapeutics has raised $54.9M.
-
Who are Sollis Therapeutics’s investors?
Cardinal Health, Medtronic, The Ohio State University, Ohio Department of Development, and Neurotechnology Innovations Translator have invested in Sollis Therapeutics.
-
Who are Sollis Therapeutics’s competitors?
Bridge Therapeutics, Phoenix PharmaLabs, Semnur Pharmaceuticals, Centrexion Therapeutics, and Pacira BioSciences are some of the 17 competitors of Sollis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process